These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24674882)

  • 21. Mouse models of systemic lupus erythematosus reveal a complex pathogenesis.
    Rottman JB; Willis CR
    Vet Pathol; 2010 Jul; 47(4):664-76. PubMed ID: 20448279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of B cells in SLE: rationale and therapeutic opportunities.
    Silverman GJ
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):51-6. PubMed ID: 17121490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.
    Moulton VR; Suarez-Fueyo A; Meidan E; Li H; Mizui M; Tsokos GC
    Trends Mol Med; 2017 Jul; 23(7):615-635. PubMed ID: 28623084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal.
    Katsiari CG; Liossis SN; Sfikakis PP
    Semin Arthritis Rheum; 2010 Jun; 39(6):491-503. PubMed ID: 19147182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
    Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
    J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS; Van Noordin S; Krausz T; Davies KA
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.
    Sharabi A; Mozes E
    Immunotherapy; 2009 May; 1(3):385-401. PubMed ID: 20635958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus.
    Jacobi AM; Diamond B
    J Exp Med; 2005 Aug; 202(3):341-4. PubMed ID: 16061723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [BCMA and autoantibody-producing RP105 B cells; possible new targets of B cell therapy in systemic lupus erythematosus].
    Koarada S; Tashiro S; Suematsu R; Inoue H; Ohta A; Tada Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):38-45. PubMed ID: 22374441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells.
    Scheinecker C; Bonelli M; Smolen JS
    J Autoimmun; 2010 Nov; 35(3):269-75. PubMed ID: 20638240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New treatments for SLE: cell-depleting and anti-cytokine therapies.
    Anolik JH; Aringer M
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus.
    Pierdominici M; Vomero M; Barbati C; Colasanti T; Maselli A; Vacirca D; Giovannetti A; Malorni W; Ortona E
    FASEB J; 2012 Apr; 26(4):1400-12. PubMed ID: 22247332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein phosphorylation and kinome profiling reveal altered regulation of multiple signaling pathways in B lymphocytes from patients with systemic lupus erythematosus.
    Taher TE; Parikh K; Flores-Borja F; Mletzko S; Isenberg DA; Peppelenbosch MP; Mageed RA
    Arthritis Rheum; 2010 Aug; 62(8):2412-23. PubMed ID: 20506108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scavenger receptors as regulators of natural antibody responses and B cell activation in autoimmunity.
    Jordö ED; Wermeling F; Chen Y; Karlsson MC
    Mol Immunol; 2011 Jun; 48(11):1307-18. PubMed ID: 21333356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cells as effectors and regulators of autoimmunity.
    Mariño E; Grey ST
    Autoimmunity; 2012 Aug; 45(5):377-87. PubMed ID: 22432804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement deficiencies in humans and animals: links to autoimmunity.
    Lewis MJ; Botto M
    Autoimmunity; 2006 Aug; 39(5):367-78. PubMed ID: 16923536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of B cells to lupus pathogenesis.
    Sang A; Zheng YY; Morel L
    Mol Immunol; 2014 Dec; 62(2):329-38. PubMed ID: 24332482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.
    Jacob N; Stohl W
    Autoimmunity; 2010 Feb; 43(1):84-97. PubMed ID: 20014977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.